A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.
Harmony wins orphan drug tag for pitolisant to treat Prader-Willi syndrome – Pharmaceutical Technology
Share this article Harmony reported Wakix (pitolisant) sales of $582m for full-year 2023, according to its annual report. Credit: rafapress via Shutterstock. US-based biopharmaceutical company